Back to top
more

CVS Health (CVS)

(Real Time Quote from BATS)

$68.07 USD

68.07
4,474,526

+0.62 (0.92%)

Updated Apr 30, 2024 02:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (234 out of 251)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

CVS Health Adopts Epic EHR for Specialty Care Programs

CVS Health Corporation (CVS) recently announced that it has chosen Epic as the electronic health record (EHR) system for CVS Specialty's care management programs.

    CVS Health (CVS) Beats on Q4 Earnings, Retains '17 View

    CVS Health Corporation (CVS) reported fourth-quarter 2016 adjusted earnings per share (EPS) of $1.71, up 11.8% year over year.

      CVS Health Tops Q4 Earnings, Misses on Revenues

      CVS Health posted mixed fourth quarter results with earnings beating the Zacks Consensus Estimate while sales missed the mark.

        Paycom Software (PAYC) Q4 Earnings: What's in the Cards?

        Paycom Software, Inc. (PAYC) is set to report fourth-quarter 2016 results on Feb 8.

          Broadridge Financial (BR) Q2 Earnings: What's in Store?

          Broadridge Financial Solutions Inc. (BR) is set to report fiscal second-quarter 2017 results on Feb 8.

            CDW Corp. (CDW) Q4 Earnings: What's in the Cards this Time?

            CDW Corp. (CDW) is set to report fourth-quarter 2016 results on Feb 7.

              Marsh & McLennan (MMC): Will it Disappoint in Q4 Earnings? (Revised)

              Marsh & McLennan Companies, Inc. (MMC) is scheduled to report fourth-quarter and full-year 2016 results on Feb 2.

                Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4? (Revised)

                We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.

                  Marsh & McLennan (MMC): Will it Disappoint in Q4 Earnings?

                  Marsh & McLennan Companies, Inc. (MMC) is scheduled to report fourth-quarter and full-year 2016 results on Feb 2.

                    Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4?

                    We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.

                      Rite Aid Down on Walgreens Deal Offer Price Cut & Delay

                      Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) jointly agreed upon a Jul 31, 2017 deadline for the deal and slashed the offer price to accommodate more store divestitures that would help gain regulatory approval.

                        Paylocity Holding (PCTY) Q2 Earnings: What's in the Cards?

                        Paylocity Holding Corporation (PCTY) is set to report second-quarter fiscal 2017 results on Feb 2.

                          Teladoc (TDOC) to Report Q4 Earnings: What's in Store? (revised)

                          Telehealth provider Teladoc Inc. (TDOC) has not confirmed the time/date for its December-quarter earnings release yet, but the report will likely be fairly soon, as they last reported quarterly results on October 27, 2016.

                            NXP Semiconductors (NXPI) Q4 Earnings: Will it Surprise?

                            NXP Semiconductors NV (NXPI) is set to report fourth-quarter 2016 results on Feb 1.

                              CVS Health (CVS) Q4 Earnings: A Beat in Store for the Stock?

                              We expect pharmacy innovation company CVS Health Corporation (CVS) to beat expectations when it reports fourth-quarter 2016 results on Feb 9.

                                Teladoc (TDOC) to Report Q4 Earnings: What's in Store?

                                Telehealth provider, Teladoc Inc. (TDOC ) is scheduled to report fourth-quarter and full-year 2016 results on Jan 27.

                                  Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlighted as Zacks Bull and Bear of the Day

                                  Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlighted as Zacks Bull and Bear of the Day

                                    Madeleine Johnson headshot

                                    CVS Debuts Cheap EpiPen Alternative

                                    On Thursday, leading drug store chain CVS Health Corp. (CVS) announced that it is now selling a cheaper alternative to Mylan's (MYL) EpiPen.

                                      Rite Aid (RAD) Q3 Earnings Lag, Walgreens Merger on Track

                                      Rite Aid (RAD) posted dismal third-quarter fiscal 2016 results.

                                        CVS Health (CVS) Down on Prevailing Risks, Tepid Guidance

                                        In Dec 19, 2016, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS)

                                          CVS Health Revises View for 2016 & 2017, Declares Dividend

                                          CVS Health Corporation (CVS) recently announced strategies to drive long-term growth and shareholders' value.

                                            CVS Health Introduces Transform Diabetes Care Program

                                            CVS Health Corporation (CVS) recently unveils Transform Diabetes Care Program which will help the company's PBM clients improve health outcome of diabetic patients.

                                              Madeleine Johnson headshot

                                              Target Soars 8% on Strong Q3 Earnings, E-Commerce Growth

                                              On Wednesday, shares of everyone's favorite store, Target Corp. (TGT), are soaring, up around 8% to $77 per share in morning trading after the company posted impressive third quarter financial results.

                                                Company News for November 09, 2016

                                                Companies in the News are: VRX,CVS,DHI,HTZ

                                                  Stock Market News for July 28, 2016